Study monitors safety of approved medical products using a national data network, indicating its potential as a resource.
Using the distributed data network of the new Mini-Sentinel program, the FDA can now query the electronic health information of more than 60 million people, posing specific questions in order to monitor the safety of approved medical products.
No takes yet. Share an insight, caveat, or question.
Behrman et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: